13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001214659-25-012291
Total Value
$875.5M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 3,670,206 | $95.4M | 10.90% |
| 2 | TANGO THERAPEUTICS INC | TNGX | 10,736,000 | $55.0M | 6.28% |
| 3 | COGENT BIOSCIENCES INC | COGT | 6,964,375 | $50.0M | 5.71% |
| 4 | OCULAR THERAPEUTIX INC | OCUL | 5,319,148 | $49.4M | 5.64% |
| 5 | CIDARA THERAPEUTICS INC | 171757206 | 1,005,901 | $49.0M | 5.60% |
| 6 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 6,056,596 | $46.3M | 5.29% |
| 7 | AMYLYX PHARMACEUTICALS INC | AMLX | 5,943,812 | $38.1M | 4.35% |
| 8 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,890,816 | $38.0M | 4.34% |
| 9 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $36.1M | 4.13% |
| 10 | DYNE THERAPEUTICS INC | DYN | 3,766,660 | $35.9M | 4.10% |
| 11 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $33.6M | 3.84% |
| 12 | UPSTREAM BIO INC | UPB | 2,801,763 | $30.8M | 3.51% |
| 13 | SAVARA INC | SVRA | 12,362,205 | $28.2M | 3.22% |
| 14 | DIANTHUS THERAPEUTICS INC | DNTH | 1,501,624 | $28.0M | 3.20% |
| 15 | TYRA BIOSCIENCES INC | TYRA | 2,898,103 | $27.7M | 3.17% |
| 16 | DISC MEDICINE INC | IRON | 465,257 | $24.6M | 2.81% |
| 17 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $23.6M | 2.70% |
| 18 | Agios Pharmaceuticals, Inc. | AGIO | 697,003 | $23.2M | 2.65% |
| 19 | STRUCTURE THERAPEUTICS INC | GPCR | 1,063,000 | $22.0M | 2.52% |
| 20 | XENCOR INC | XNCR | 2,452,138 | $19.3M | 2.20% |
| 21 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $17.6M | 2.01% |
| 22 | SOLENO THERAPEUTICS INC | SLNO | 186,250 | $15.6M | 1.78% |
| 23 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,761,861 | $14.8M | 1.69% |
| 24 | RAPT Therapeutics, Inc. | 75382E208 | 1,636,275 | $13.1M | 1.50% |
| 25 | THIRD HARMONIC BIO INC | 88427A107 | 1,915,424 | $10.4M | 1.19% |
| 26 | Enliven Therapeutics, Inc. | ELVN | 498,000 | $10.0M | 1.14% |
| 27 | MBX BIOSCIENCES INC | MBX | 650,000 | $7.4M | 0.85% |
| 28 | NEKTAR THERAPEUTICS | NKTR | 266,666 | $6.9M | 0.79% |
| 29 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $5.4M | 0.61% |
| 30 | KODIAK SCIENCES INC | KOD | 1,145,538 | $4.3M | 0.49% |
| 31 | KURA ONCOLOGY INC | KURA | 735,184 | $4.2M | 0.48% |
| 32 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $3.9M | 0.45% |
| 33 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,796,482 | $3.9M | 0.44% |
| 34 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $2.4M | 0.28% |
| 35 | VENTYX BIOSCIENCES INC | 92332V107 | 316,195 | $676,657 | 0.08% |
| 36 | JADE BIOSCIENCES INC | JBIO | 64,023 | $639,590 | 0.07% |
| 37 | CABALETTA BIO INC | CABA | 86,795 | $131,928 | 0.02% |
| 38 | KEROS THERAPEUTICS INC | KROS | 0 | $0 | 0.00% |